New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
09:36 EDTPFNXPfenex IPO indicated to open $5.75-$6.00 on 100K shares
Pfenex (PFNX) priced 8.33M shares at $6.00. William Blair and JMP Securities acted as joint book running managers for the offering.
News For PFNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
17:10 EDTPFNXPfenex files to sell 5.23M shares of common stock for holders
Subscribe for More Information
17:09 EDTPFNXPfenex files $120M mixed securities shelf
Subscribe for More Information
August 17, 2015
08:04 EDTPFNXPfenex awarded HHS contract valued at up to $143.5M
Pfenex announced it has signed a five year, cost plus fixed fee contract valued at up to $143.5M with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the advanced development of Px563L, a mutant recombinant protective antigen anthrax vaccine. Under the contract, the base period will fund activities related to current Good Manufacturing Practice (cGMP) manufacturing of drug product and a Phase 1a clinical study. Milestone-based option periods include completion of a Phase 1b clinical study, a Phase 2 clinical study and non-clinical efficacy studies as well as manufacturing technology transfer and optimization, process and analytical method validation and consistency lot manufacture. Pfenex believes the successful completion of the activities under this contract could lead to a procurement contract for supply of Px563L to the Strategic National Stockpile.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use